Researchers

Lina Bergman

Lina Bergman

MD, Specialist Obsterics and Gynecology, Associate professor

Research:
Prinicipal investigator for neurological complications in PROVE, Principal investigator for GO-PROVE, Co-investigator for IMPACT

Lina is a researcher and clinician, focusing on preeclampsia and organ complications as well as prediction of disease. She is working at Gothenburg University but also affiliated to Uppsala University and Stellenbosch University.

Catherine Cluver

Catherine Cluver

MD, Subspecialist Maternal-Fetal Medicine, Associate Professor

Research:
Principal investigator for PROVE, Principal investigator for PI trials

Catherine is a researcher and clinician, working as a maternal-fetal medicine specialist in Cape Town and leading clinical trials for preeclampsia research at Tygerberg Hospital, Stellenbosch University. She is also affiliated researcher at Mercy Perinatal, Melbourne.

Sonja Schell

Sonja Schell

Preeclampsia Research Unit Coordinator

Research:
Leads the research midwife team for the PROVE and the Preeclampsia Intervention Trials

Sonja completed a Diploma in general nursing, psychiatry, community health and midwifery followed by a diploma in paediatrics and neonatology.

 

 

Anna-Karin Wikström

Anna-Karin Wikström

MD, Specialist Obstetrics and Gynecology, Professor

Research:
Prinicpal investigator for IMPACT, principal investigator  for UPMOST, epidemiologist

Anna-Karin is a professor at Uppsala University. She works mainly with preeclampsia research in the fields of epidemiology and observational clinical studies. 

Susanne Hesselman

Susanne Hesselman

MD, PhD, senior consultant Ob/Gyn Falun Hospital, Sweden

Research:
Epidemiological studies of preeclampsia and labour, affiliated researcher at Uppsala University

Susanne’s research focuses on epidemiological studies of adverse pregnancy outcomes in the Swedish national and quality registers. 

Roxanne Hastie

Roxanne Hastie

BiomedSc, BSc (Hons), M Epi, PhD, researcher at Mercy Perinatal and affiliated researcher at Uppsala University

Research:
Laboratory based studies and epidemiological studies, Principal investigator for ICE and co-investigator for PROVE

Roxanne is a research scientist dual skilled in complex laboratory and epidemiology research. Roxanne’s research aims to combine these streams to undertake translational research that reduces the burden of major pregnancy complications, including preeclampsia. Roxanne works at the University of Melbourne and Mercy Perinatal and holds an affiliated research position with Uppsala University.

Carlos Escudero Orozco

Carlos Escudero Orozco

MD, PhD (Biomedical Sciences), Full-professor Universidad del Bio Bio

Research:
In vitro studies of the vasculature in preeclampsia with material from PROVE, GO PROVE and UPMOST focusing on brain endothelial cells  

Carlos Escudero is a vascular physiologist. His current area of interest is to understand the potential negative consequences of preeclampsia in the brain vascular formation and the integrity of the blood-brain barrier in mother and babies exposed to preeclampsia.

Verena Sengpiel

Verena Sengpiel

MD, Specialist Obstetrics and Gynecology, Associate Professor

Research:
Co-investigator for GoProve

Verena works as clinician at Sahlgrenska University Hospital and researcher at Gothenburg University.

Isabella Björkman-Burtscher

Isabella Björkman-Burtscher

MD, professor in neuroradiology

Research:
Co-investigator for GO PROVE

Isabella is a professor in Neuroradiology at Sahlgrenska Academy and in charge for the MR protocol in GO PROVE/UPMOST together with Johan Wikström.

Susanne Lager

Susanne Lager

MSc, PhD, associate professor

Research:
Co-investigator for UPMOST

Susanne Lager is a Senior Lecture in laboratory science at the Department of Women’s and Children’s Health, Uppsala University, Sweden.

Helmuth Reuter

Helmuth Reuter

Professor, Head of Division of Clinical Pharmacology, Stellenbosch University

Research:
Pharmacokinetics studies for preeclampsia treatment

Helmuth Reuter is a professor of internal medicine and clinical pharmacology, currently heading the Division of Clinical Pharmacology (at the Faculty of Medicine and Health Sciences) at Stellenbosch University.

 

Tu’uhevaha Kaitu’u-Lino

Tu’uhevaha Kaitu’u-Lino

BBiomedSci (hons), PhD. Associate Professor at the University of Melbourne

Research:
Laboratory studies to identify new biomarkers for Preeclampsia and to study the pathogenesis of the disease

Tu’uhevaha is head of the Diagnostics Discovery and Reverse Translation Group at the University of Melbourne and Mercy Perinatal.

 

Eric Decloedt

Eric Decloedt

Associate Professor, Division of Clinical Pharmacology, Stellenbosch University

Research:
Co-investigator for Preeclampsia Intervention trials, Pharmacokinetics studies for preeclampsia treatment

Eric Decloedt is an associate professor and a medical specialist in clinical pharmacology.

 

Ahmed A. Abulfathi

Ahmed A. Abulfathi

Senior lecturer and PhD candidate, Division of Clinical Pharmacology, Stellenbosch University

Research:
Pharmacokinetics studies for preeclampsia treatment

Ahmed A. Abulfathi is a Lecturer in the Department of Clinical Pharmacology and Therapeutics, University of Maiduguri, Nigeria, a Clinical Pharmacologist and PhD candidate at Stellenbosch University, South Africa, and Researcher at the Arctic University (UiT), Norway.

 

 

Elin Svensson

Elin Svensson

MSc, PhD, docent at Uppsala university and researcher at Radboud university medical center

Research:
Pharmacometric analysis for preeclampsia studies

Elin Svensson is a pharmacometrician using population pharmacokinetic and pharmacodynamic modeling to understand exposure-response relationships and improve therapies.

 

 

Michael A. Belfort

Michael A. Belfort

Chairman and Professor, Department of Obstetrics and Gynecology

Research:
Co-investigator for cerebral autoregulation in preeclampsia within PROVE

Professor Belfort is a co-investigator for cerebral autoregulation in preeclampsia within PROVE

 

Ronney Panerai

Ronney Panerai

Professor

Research:
Participates in the studies of cerebral autoregulation in PROVE, GO PROVE and UPMOST

Professor Panerai is an expert in the field of cerebral autoregulation and participates in the studies of cerebral autoregulation in PROVE, GO PROVE and UPMOST

 

Teelkien van Veen

Teelkien van Veen

MD, PhD

Research:
Co-investigator in PROVE, GO PROVE and UPMOST, focusing on cerebral autoregulation in preeclampsia

Co-investigator in PROVE, GO PROVE and UPMOST, focusing on cerebral autoregulation in preeclampsia

 

Lilja Thorunn Thorgeirsdottir

Lilja Thorunn Thorgeirsdottir

RN, RNM, PhD student

Research:
Co-investigator for Go-Prove

Lilja is a midwife at Sahlgrenska University Hospital and a PhD student at Gothenburg University

 

Eduard Langenegger

Eduard Langenegger

MD, PHD. Subspecialist in Maternal Fetal-Medicine and Obstetric Critical Care

Research:
Co-investigator for Prove

Eduard is a clinician and researcher. He established an obstetric critical care unit (OOCU) at Tygerberg Hospital, University of Stellenbosch.

 

Helen Elden

Helen Elden

PhD, Associate professor, RNM

Research:
Co-investigator for GO PROVE

Helen is an associate professor in reproductive and perinatal health and a senior lecturer and the research group leader for the Childbirth research group at the institution of health and care sciences, the Sahlgrenska academy, University of Gothenburg.

 

Malin Andersson

Malin Andersson

MD

Research:
Phd student in GO-PROVE

Malin is a senior consultant in Anesthesiology and Intensive Care at Östra sjukhuset/ Sahlgrenska University Hospital Gothenburg, Sweden.

 

 Maria MacGregor

Maria MacGregor

Research:
Research assistant for GO-PROVE

Maria is a graduate student of the University of Gothenburg, where she earned a Master of Medical Science degree in Global Health.